Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company focused on developing cancer therapies. The company has a pipeline of drug candidates targeting precision RAS pathway therapies and next-generation PD-1/L1 pathway modulating immunotherapies. Adlai Nortye collaborates with various pharmaceutical companies to enhance drug discovery and development, aiming to provide treatment options for patients worldwide.
- Website
- www.adlainortye.com
- Issuer profile
- All listings